| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 21 | 2022 | 719 | 5.700 |
Why?
|
| Inflammasomes | 7 | 2021 | 161 | 3.300 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 15 | 2019 | 244 | 2.600 |
Why?
|
| Myocytes, Cardiac | 12 | 2021 | 764 | 1.580 |
Why?
|
| Tankyrases | 3 | 2019 | 9 | 1.470 |
Why?
|
| Sarcoplasmic Reticulum | 9 | 2019 | 191 | 1.390 |
Why?
|
| Calcium | 11 | 2021 | 1537 | 1.210 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 4 | 2021 | 112 | 1.190 |
Why?
|
| Calcium Signaling | 9 | 2021 | 284 | 1.180 |
Why?
|
| Heart Atria | 6 | 2021 | 352 | 1.170 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 7 | 2018 | 184 | 1.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2019 | 324 | 1.010 |
Why?
|
| Tachycardia, Ventricular | 5 | 2022 | 239 | 0.940 |
Why?
|
| Yolk Sac | 1 | 2022 | 26 | 0.840 |
Why?
|
| Organogenesis | 1 | 2023 | 119 | 0.840 |
Why?
|
| Vascular Remodeling | 1 | 2022 | 48 | 0.830 |
Why?
|
| Heart Rate | 4 | 2021 | 737 | 0.820 |
Why?
|
| Embryo Implantation | 1 | 2023 | 278 | 0.750 |
Why?
|
| Mindfulness | 1 | 2021 | 58 | 0.730 |
Why?
|
| Proteostasis | 1 | 2020 | 52 | 0.710 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2019 | 413 | 0.700 |
Why?
|
| Behcet Syndrome | 1 | 2019 | 17 | 0.700 |
Why?
|
| Psychology, Adolescent | 1 | 2019 | 41 | 0.670 |
Why?
|
| Down-Regulation | 5 | 2019 | 2074 | 0.670 |
Why?
|
| Epigenetic Repression | 1 | 2018 | 9 | 0.660 |
Why?
|
| Anger | 1 | 2018 | 21 | 0.650 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2018 | 47 | 0.640 |
Why?
|
| Zebrafish Proteins | 2 | 2018 | 163 | 0.640 |
Why?
|
| Animals | 42 | 2023 | 59536 | 0.640 |
Why?
|
| Radiation Tolerance | 2 | 2018 | 629 | 0.630 |
Why?
|
| Microtubules | 2 | 2018 | 270 | 0.630 |
Why?
|
| Histone Demethylases | 2 | 2016 | 144 | 0.620 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2019 | 214 | 0.620 |
Why?
|
| Personal Autonomy | 1 | 2019 | 212 | 0.590 |
Why?
|
| Peroxisomes | 1 | 2017 | 49 | 0.590 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 169 | 0.590 |
Why?
|
| Tetracaine | 1 | 2016 | 9 | 0.590 |
Why?
|
| Disease Models, Animal | 16 | 2021 | 7222 | 0.590 |
Why?
|
| Parent-Child Relations | 1 | 2019 | 257 | 0.580 |
Why?
|
| Uric Acid | 1 | 2016 | 75 | 0.580 |
Why?
|
| Hyperuricemia | 1 | 2016 | 34 | 0.580 |
Why?
|
| Mice | 29 | 2023 | 34495 | 0.570 |
Why?
|
| Pyrimidinones | 1 | 2018 | 314 | 0.560 |
Why?
|
| Zebrafish | 2 | 2018 | 463 | 0.560 |
Why?
|
| DNA Repair Enzymes | 1 | 2017 | 237 | 0.560 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2022 | 226 | 0.560 |
Why?
|
| Channelopathies | 1 | 2016 | 10 | 0.550 |
Why?
|
| Cadherins | 2 | 2018 | 660 | 0.540 |
Why?
|
| Pyridones | 1 | 2018 | 348 | 0.540 |
Why?
|
| Myocardium | 7 | 2014 | 1313 | 0.540 |
Why?
|
| Mice, Knockout | 13 | 2023 | 5710 | 0.530 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 362 | 0.530 |
Why?
|
| Learning | 1 | 2019 | 403 | 0.520 |
Why?
|
| Nerve Tissue Proteins | 2 | 2022 | 1491 | 0.510 |
Why?
|
| Myocardial Infarction | 4 | 2019 | 1374 | 0.500 |
Why?
|
| DNA-Binding Proteins | 2 | 2018 | 4821 | 0.500 |
Why?
|
| Inflammation | 4 | 2021 | 2522 | 0.490 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 1879 | 0.490 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 479 | 0.490 |
Why?
|
| Gene Knockdown Techniques | 4 | 2019 | 1077 | 0.490 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2014 | 17 | 0.490 |
Why?
|
| Epigenomics | 1 | 2015 | 266 | 0.480 |
Why?
|
| Cytoskeleton | 1 | 2015 | 267 | 0.480 |
Why?
|
| Signal Transduction | 9 | 2021 | 11965 | 0.470 |
Why?
|
| Energy Metabolism | 1 | 2019 | 992 | 0.460 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 907 | 0.450 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2022 | 473 | 0.440 |
Why?
|
| Lung Neoplasms | 5 | 2021 | 11538 | 0.440 |
Why?
|
| Electric Stimulation | 2 | 2012 | 426 | 0.440 |
Why?
|
| MicroRNAs | 3 | 2015 | 2947 | 0.440 |
Why?
|
| Proteomics | 5 | 2021 | 1380 | 0.440 |
Why?
|
| Cell Movement | 3 | 2018 | 2466 | 0.430 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 862 | 0.430 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2021 | 5319 | 0.430 |
Why?
|
| Chemoradiotherapy | 1 | 2021 | 1946 | 0.430 |
Why?
|
| Actins | 1 | 2015 | 608 | 0.420 |
Why?
|
| Salivary Glands, Minor | 1 | 2011 | 33 | 0.420 |
Why?
|
| Humans | 47 | 2023 | 261506 | 0.420 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2016 | 1064 | 0.410 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1331 | 0.400 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2011 | 87 | 0.400 |
Why?
|
| RNA, Messenger | 3 | 2018 | 6150 | 0.390 |
Why?
|
| Prostatic Neoplasms | 3 | 2018 | 5767 | 0.390 |
Why?
|
| Heart Failure | 6 | 2019 | 2516 | 0.380 |
Why?
|
| Decision Making | 1 | 2018 | 1287 | 0.370 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 803 | 0.350 |
Why?
|
| Mutation | 9 | 2019 | 15179 | 0.350 |
Why?
|
| Gene Expression | 1 | 2017 | 3570 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 6942 | 0.340 |
Why?
|
| Histones | 1 | 2016 | 1466 | 0.340 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 8873 | 0.330 |
Why?
|
| Obesity | 1 | 2021 | 2884 | 0.330 |
Why?
|
| Action Potentials | 4 | 2021 | 560 | 0.330 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2010 | 253 | 0.310 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2011 | 421 | 0.310 |
Why?
|
| Cell Line, Tumor | 8 | 2019 | 14551 | 0.300 |
Why?
|
| Transcription Factors | 3 | 2018 | 5270 | 0.300 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2011 | 489 | 0.300 |
Why?
|
| Protein Phosphatase 1 | 2 | 2019 | 79 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 2359 | 0.290 |
Why?
|
| Phosphoproteins | 3 | 2019 | 1152 | 0.290 |
Why?
|
| Proteolysis | 2 | 2020 | 370 | 0.280 |
Why?
|
| DNA Methylation | 1 | 2016 | 2669 | 0.280 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2016 | 110 | 0.270 |
Why?
|
| Proteome | 2 | 2020 | 561 | 0.270 |
Why?
|
| Mice, Transgenic | 8 | 2019 | 4143 | 0.260 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2018 | 69 | 0.260 |
Why?
|
| Sulfones | 3 | 2019 | 143 | 0.240 |
Why?
|
| Calcium-Binding Proteins | 2 | 2019 | 545 | 0.230 |
Why?
|
| Arteries | 2 | 2022 | 274 | 0.220 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 4638 | 0.220 |
Why?
|
| Heart Conduction System | 2 | 2014 | 165 | 0.220 |
Why?
|
| Carcinogenesis | 2 | 2019 | 1026 | 0.210 |
Why?
|
| X-Ray Microtomography | 1 | 2023 | 141 | 0.210 |
Why?
|
| Gene Knock-In Techniques | 3 | 2019 | 171 | 0.210 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 14289 | 0.210 |
Why?
|
| Mice, Nude | 3 | 2019 | 4307 | 0.200 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2021 | 8 | 0.200 |
Why?
|
| Cell Proliferation | 4 | 2019 | 7226 | 0.200 |
Why?
|
| Sheep, Domestic | 1 | 2021 | 21 | 0.200 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2022 | 167 | 0.200 |
Why?
|
| Cardiomyopathies | 2 | 2022 | 610 | 0.200 |
Why?
|
| Dependovirus | 2 | 2019 | 135 | 0.200 |
Why?
|
| Transfection | 2 | 2016 | 2944 | 0.190 |
Why?
|
| HEK293 Cells | 4 | 2019 | 1489 | 0.190 |
Why?
|
| Fibrosis | 4 | 2019 | 793 | 0.190 |
Why?
|
| MCF-7 Cells | 2 | 2019 | 550 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2019 | 3821 | 0.180 |
Why?
|
| Case-Control Studies | 3 | 2021 | 6100 | 0.180 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2019 | 14 | 0.180 |
Why?
|
| Ventricular Remodeling | 4 | 2012 | 248 | 0.180 |
Why?
|
| para-Aminobenzoates | 1 | 2019 | 10 | 0.180 |
Why?
|
| Universities | 1 | 2021 | 160 | 0.180 |
Why?
|
| Female | 20 | 2021 | 141928 | 0.180 |
Why?
|
| Silk | 1 | 2019 | 17 | 0.180 |
Why?
|
| Male | 17 | 2021 | 123000 | 0.180 |
Why?
|
| Natriuretic Peptide, C-Type | 1 | 2019 | 16 | 0.170 |
Why?
|
| Armadillo Domain Proteins | 1 | 2019 | 21 | 0.170 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 15694 | 0.170 |
Why?
|
| Aging | 3 | 2022 | 1582 | 0.170 |
Why?
|
| Up-Regulation | 5 | 2020 | 2450 | 0.170 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 741 | 0.170 |
Why?
|
| Adolescent Development | 1 | 2019 | 34 | 0.170 |
Why?
|
| Phosphorylation | 8 | 2019 | 4804 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 1439 | 0.160 |
Why?
|
| Phosphoramide Mustards | 1 | 2018 | 37 | 0.160 |
Why?
|
| Cross-Cultural Comparison | 1 | 2019 | 87 | 0.160 |
Why?
|
| Parenting | 2 | 2021 | 345 | 0.160 |
Why?
|
| Mothers | 1 | 2021 | 410 | 0.160 |
Why?
|
| HeLa Cells | 2 | 2019 | 1643 | 0.160 |
Why?
|
| Students | 1 | 2021 | 324 | 0.160 |
Why?
|
| Patch-Clamp Techniques | 3 | 2018 | 388 | 0.160 |
Why?
|
| Aurora Kinase B | 1 | 2018 | 68 | 0.160 |
Why?
|
| Atrial Remodeling | 1 | 2018 | 12 | 0.160 |
Why?
|
| Nitroimidazoles | 1 | 2018 | 100 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 2 | 2016 | 3981 | 0.160 |
Why?
|
| Wernicke Area | 1 | 2017 | 11 | 0.160 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2023 | 925 | 0.150 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2017 | 84 | 0.150 |
Why?
|
| Triazoles | 2 | 2019 | 617 | 0.150 |
Why?
|
| Protein Precursors | 1 | 2019 | 240 | 0.150 |
Why?
|
| Heart Arrest | 1 | 2022 | 358 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2020 | 854 | 0.150 |
Why?
|
| Embryo, Nonmammalian | 1 | 2018 | 234 | 0.150 |
Why?
|
| Educational Status | 1 | 2019 | 397 | 0.150 |
Why?
|
| China | 1 | 2019 | 606 | 0.150 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 3154 | 0.150 |
Why?
|
| Thiazepines | 1 | 2016 | 14 | 0.150 |
Why?
|
| Receptors for Activated C Kinase | 1 | 2016 | 7 | 0.150 |
Why?
|
| In Situ Hybridization | 2 | 2017 | 1037 | 0.150 |
Why?
|
| Substance-Related Disorders | 1 | 2021 | 524 | 0.140 |
Why?
|
| Neutrophils | 2 | 2019 | 835 | 0.140 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 358 | 0.140 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 987 | 0.140 |
Why?
|
| Genetic Vectors | 2 | 2019 | 1694 | 0.140 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 538 | 0.140 |
Why?
|
| 3' Untranslated Regions | 2 | 2014 | 343 | 0.140 |
Why?
|
| Psychometrics | 1 | 2021 | 937 | 0.140 |
Why?
|
| Gene Editing | 1 | 2018 | 216 | 0.140 |
Why?
|
| Membrane Proteins | 3 | 2019 | 2819 | 0.140 |
Why?
|
| Speech | 1 | 2017 | 133 | 0.140 |
Why?
|
| Phenotype | 4 | 2023 | 6295 | 0.140 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 4053 | 0.140 |
Why?
|
| Embryonic Development | 1 | 2018 | 306 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2022 | 1048 | 0.140 |
Why?
|
| Human papillomavirus 16 | 1 | 2017 | 256 | 0.130 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 716 | 0.130 |
Why?
|
| Social Support | 1 | 2019 | 560 | 0.130 |
Why?
|
| RNA Interference | 2 | 2018 | 1408 | 0.130 |
Why?
|
| Anesthetics, Local | 1 | 2016 | 163 | 0.130 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 323 | 0.130 |
Why?
|
| Prognosis | 4 | 2018 | 21713 | 0.130 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 280 | 0.130 |
Why?
|
| Language | 1 | 2017 | 309 | 0.130 |
Why?
|
| Acetylation | 1 | 2016 | 508 | 0.130 |
Why?
|
| Protein Binding | 3 | 2016 | 3438 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 2018 | 750 | 0.130 |
Why?
|
| Binding Sites | 2 | 2016 | 2171 | 0.130 |
Why?
|
| Exocytosis | 1 | 2015 | 111 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 2314 | 0.130 |
Why?
|
| Age Factors | 3 | 2014 | 5377 | 0.120 |
Why?
|
| Homeostasis | 1 | 2019 | 950 | 0.120 |
Why?
|
| Optical Imaging | 1 | 2015 | 157 | 0.120 |
Why?
|
| COUP Transcription Factor I | 1 | 2013 | 81 | 0.120 |
Why?
|
| Time Factors | 4 | 2016 | 12926 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 6009 | 0.120 |
Why?
|
| Microarray Analysis | 1 | 2015 | 392 | 0.120 |
Why?
|
| Ear, Inner | 1 | 2013 | 57 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1945 | 0.110 |
Why?
|
| Neoplasms | 1 | 2019 | 15193 | 0.110 |
Why?
|
| Protein Conformation | 1 | 2016 | 1258 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 663 | 0.110 |
Why?
|
| DNA Primers | 1 | 2015 | 1399 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2018 | 846 | 0.110 |
Why?
|
| Wnt Proteins | 1 | 2015 | 397 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2019 | 5637 | 0.110 |
Why?
|
| Cardiomegaly | 2 | 2012 | 195 | 0.110 |
Why?
|
| Cytokines | 3 | 2018 | 2809 | 0.110 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 2195 | 0.110 |
Why?
|
| Social Class | 1 | 2014 | 310 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 650 | 0.100 |
Why?
|
| Autophagy | 1 | 2018 | 927 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 1217 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2016 | 1732 | 0.100 |
Why?
|
| Ovary | 1 | 2015 | 668 | 0.100 |
Why?
|
| beta Catenin | 1 | 2015 | 688 | 0.100 |
Why?
|
| Immunohistochemistry | 4 | 2017 | 7548 | 0.100 |
Why?
|
| Antibodies, Viral | 1 | 2017 | 1320 | 0.100 |
Why?
|
| Genetic Therapy | 1 | 2018 | 1616 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2011 | 274 | 0.090 |
Why?
|
| Adolescent | 4 | 2019 | 31252 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 1487 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2016 | 1987 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 778 | 0.090 |
Why?
|
| Mice, Inbred mdx | 3 | 2018 | 44 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 1143 | 0.090 |
Why?
|
| Cell Line | 1 | 2018 | 5114 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2014 | 1764 | 0.090 |
Why?
|
| Biomarkers | 3 | 2021 | 5047 | 0.090 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 1724 | 0.090 |
Why?
|
| Electrocardiography | 3 | 2010 | 1145 | 0.090 |
Why?
|
| Sudden Infant Death | 1 | 2009 | 33 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 234 | 0.090 |
Why?
|
| Smad3 Protein | 1 | 2010 | 129 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 677 | 0.090 |
Why?
|
| Eye Neoplasms | 1 | 2011 | 247 | 0.090 |
Why?
|
| Models, Animal | 1 | 2011 | 664 | 0.080 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 4314 | 0.080 |
Why?
|
| Aged | 7 | 2021 | 70117 | 0.080 |
Why?
|
| Biomarkers, Tumor | 2 | 2018 | 10331 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2017 | 980 | 0.080 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 4988 | 0.080 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2017 | 1105 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 5687 | 0.080 |
Why?
|
| Substrate Specificity | 2 | 2020 | 549 | 0.080 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2008 | 18 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 4938 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 1823 | 0.080 |
Why?
|
| Myocardial Reperfusion | 1 | 2008 | 108 | 0.080 |
Why?
|
| Disease Progression | 3 | 2014 | 6682 | 0.080 |
Why?
|
| Isoproterenol | 2 | 2022 | 127 | 0.080 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2008 | 112 | 0.080 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2020 | 146 | 0.080 |
Why?
|
| Encephalomyocarditis virus | 1 | 2006 | 9 | 0.070 |
Why?
|
| Cardiovirus Infections | 1 | 2006 | 8 | 0.070 |
Why?
|
| Interleukin-1 | 1 | 2008 | 461 | 0.070 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2006 | 23 | 0.070 |
Why?
|
| Heat-Shock Response | 1 | 2006 | 40 | 0.070 |
Why?
|
| Genomics | 1 | 2017 | 2738 | 0.070 |
Why?
|
| Mouth Neoplasms | 1 | 2011 | 713 | 0.070 |
Why?
|
| Sex Factors | 1 | 2011 | 2139 | 0.070 |
Why?
|
| Fibroblasts | 2 | 2010 | 1682 | 0.070 |
Why?
|
| DNA Repair | 1 | 2014 | 1872 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2017 | 32848 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8865 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 3869 | 0.070 |
Why?
|
| Middle Aged | 8 | 2018 | 86204 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 5112 | 0.070 |
Why?
|
| Collagen | 1 | 2008 | 752 | 0.070 |
Why?
|
| Apoptosis | 1 | 2019 | 7591 | 0.060 |
Why?
|
| DNA | 1 | 2013 | 2693 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2018 | 3341 | 0.060 |
Why?
|
| Genital Neoplasms, Female | 1 | 2011 | 735 | 0.060 |
Why?
|
| Wound Healing | 1 | 2010 | 815 | 0.060 |
Why?
|
| Serine | 2 | 2019 | 388 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2018 | 717 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 5061 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 1866 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 5159 | 0.050 |
Why?
|
| Verapamil | 1 | 2022 | 78 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 13658 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2006 | 677 | 0.050 |
Why?
|
| Microfilament Proteins | 2 | 2015 | 487 | 0.050 |
Why?
|
| Magnesium | 1 | 2022 | 160 | 0.050 |
Why?
|
| Risk Factors | 2 | 2016 | 17523 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 1 | 2021 | 97 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2021 | 127 | 0.050 |
Why?
|
| Fetal Proteins | 1 | 2020 | 28 | 0.050 |
Why?
|
| Hypertension | 1 | 2010 | 1503 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2021 | 388 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2014 | 634 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2012 | 3536 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 7789 | 0.040 |
Why?
|
| Myocardial Contraction | 2 | 2012 | 291 | 0.040 |
Why?
|
| Young Adult | 4 | 2021 | 21445 | 0.040 |
Why?
|
| Indenes | 1 | 2018 | 11 | 0.040 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2019 | 68 | 0.040 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2009 | 127 | 0.040 |
Why?
|
| Trans-Activators | 2 | 2019 | 1555 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2018 | 162 | 0.040 |
Why?
|
| Mitochondrial Dynamics | 1 | 2019 | 62 | 0.040 |
Why?
|
| Furans | 1 | 2018 | 104 | 0.040 |
Why?
|
| NADPH Oxidase 2 | 1 | 2018 | 47 | 0.040 |
Why?
|
| Leukopenia | 1 | 2018 | 151 | 0.040 |
Why?
|
| Spindle Apparatus | 1 | 2018 | 93 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2019 | 392 | 0.040 |
Why?
|
| Mental Health | 1 | 2021 | 415 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 289 | 0.040 |
Why?
|
| Alopecia | 1 | 2018 | 126 | 0.040 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2018 | 119 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 328 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2019 | 997 | 0.040 |
Why?
|
| Dogs | 1 | 2018 | 1155 | 0.040 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 3230 | 0.040 |
Why?
|
| Chemokines | 2 | 2008 | 314 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 4971 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 798 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2017 | 344 | 0.040 |
Why?
|
| Functional Laterality | 1 | 2017 | 316 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 495 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 15862 | 0.030 |
Why?
|
| Age Distribution | 1 | 2017 | 698 | 0.030 |
Why?
|
| Inflammation Mediators | 2 | 2008 | 423 | 0.030 |
Why?
|
| Mitosis | 1 | 2018 | 615 | 0.030 |
Why?
|
| Incidence | 2 | 2017 | 5673 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 1099 | 0.030 |
Why?
|
| Dishevelled Proteins | 1 | 2015 | 59 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2011 | 4654 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2015 | 159 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 549 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2021 | 12873 | 0.030 |
Why?
|
| Texas | 2 | 2017 | 6311 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 370 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2021 | 1000 | 0.030 |
Why?
|
| Child | 3 | 2022 | 29154 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 1489 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 323 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 898 | 0.030 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2013 | 4 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 672 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2017 | 644 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 1363 | 0.030 |
Why?
|
| Echocardiography | 2 | 2010 | 1182 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 234 | 0.030 |
Why?
|
| Muscle Cells | 1 | 2012 | 38 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2013 | 146 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 193 | 0.030 |
Why?
|
| Adult | 5 | 2018 | 77950 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2020 | 1756 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 2315 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2015 | 1082 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 2008 | 1130 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 4233 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 2216 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2013 | 198 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2014 | 644 | 0.030 |
Why?
|
| Ventricular Pressure | 1 | 2012 | 46 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 430 | 0.030 |
Why?
|
| Fatigue | 1 | 2018 | 1239 | 0.030 |
Why?
|
| Macrophages | 2 | 2008 | 1304 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 270 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 1519 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2018 | 1129 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 3101 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 3254 | 0.030 |
Why?
|
| Random Allocation | 1 | 2012 | 703 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 5539 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 1070 | 0.020 |
Why?
|
| Sarcolemma | 1 | 2010 | 32 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2010 | 107 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 3890 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2010 | 77 | 0.020 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2009 | 8 | 0.020 |
Why?
|
| Theophylline | 1 | 2009 | 34 | 0.020 |
Why?
|
| Logistic Models | 1 | 2017 | 3441 | 0.020 |
Why?
|
| Adrenergic Agonists | 1 | 2009 | 14 | 0.020 |
Why?
|
| Death, Sudden | 1 | 2010 | 59 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2012 | 244 | 0.020 |
Why?
|
| Cell Size | 1 | 2010 | 136 | 0.020 |
Why?
|
| Goats | 1 | 2009 | 73 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2010 | 96 | 0.020 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2009 | 31 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 1225 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2018 | 1823 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2015 | 1620 | 0.020 |
Why?
|
| Calcineurin | 1 | 2010 | 128 | 0.020 |
Why?
|
| Epinephrine | 1 | 2009 | 255 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2010 | 292 | 0.020 |
Why?
|
| Receptor, ErbB-2 | 1 | 2018 | 2518 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2010 | 315 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 7702 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2008 | 88 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 424 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2012 | 435 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2012 | 603 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2008 | 109 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2008 | 253 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2008 | 240 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 2283 | 0.020 |
Why?
|
| Infant | 2 | 2014 | 13310 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 10001 | 0.020 |
Why?
|
| Cell Division | 1 | 2010 | 2489 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2009 | 1338 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2018 | 4975 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 6869 | 0.020 |
Why?
|
| Aorta | 1 | 2008 | 692 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 3639 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 1479 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2014 | 8223 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 4849 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 3578 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 4078 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 16273 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 4757 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 29902 | 0.010 |
Why?
|